Key Highlights

  • NaturalShrimp Inc. has secured a perpetual and exclusive license for aquaculture technology from Hydrenesis.
  • Hydrenesis would hold a combined economic ownership of 65% under the new structure.
  • The Company’s remaining liabilities are limited to $1,000,000 as stipulated in the amendment.

NaturalShrimp Inc. disclosed that it has entered into a revised licensing arrangement with Hydrenesis, granting the company a perpetual, field‑of‑use license for specific aquaculture technologies. The amendment, filed under the EXCHANGE COMMISSION Washington, D.C.

20549 docket, modifies the original agreement to preserve exclusivity while allowing NaturalShrimp to own any enhancements it creates. This shift emphasizes operational flexibility over outright ownership of the underlying intellectual property.

Licensing Transformation

Under the revised terms, NaturalShrimp will act as a perpetual licensee, employing the licensed technology across a range of aquaculture applications. Hydrenesis retains the overarching intellectual property rights, while NaturalShrimp gains the ability to commercialize the technology and any derivatives it develops. The amendment, identified as LIMITED AMENDMENT 1.1, supersedes prior transfer structures and aligns the parties’ obligations with current regulatory requirements.

Equity and Ownership Structure

The amendment also provides for the issuance of two classes of preferred stock. Series P preferred stock will represent 10% of the equity, while Series P-2 preferred stock will represent 15%. Together, these issuances allocate a combined economic ownership of 65% to Hydrenesis, reflecting the parties’ negotiated equity distribution.

No individual is named as a recipient of the preferred shares; the allocation is directed to the entities as outlined in the filing.

Financial Implications

A key financial provision of the amendment caps the Company’s remaining liabilities at $1,000,000. This limitation is intended to reduce debt exposure while supporting ongoing innovation initiatives. By controlling liability levels, NaturalShrimp aims to maintain fiscal discipline without impeding the execution of its technology roadmap.

Outlook

The effectiveness of the licensing and equity arrangements will be evaluated against performance milestones detailed in the amendment. Stakeholders are encouraged to monitor the Company’s progress in meeting these objectives, as successful execution may influence future financial and operational outcomes. The amendment’s provisions, including the PERPETUAL FIELD‑OF‑USE LICENSE (5.1) and the REPLACEMENT OF TRANSFERRED IP REFERENCES (4.1), provide a framework for sustained collaboration between NaturalShrimp and Hydrenesis throughout the remainder of the fiscal year.

Based on the Form 8‑K filed 25 June 2026.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.